Literature DB >> 22092257

A once-per-day, drug-in-food protocol for prolonged administration of antiepileptic drugs in animal models.

Atif Ali1, Yashomati Dua, Jonathan E Constance, Michael R Franklin, F Edward Dudek.   

Abstract

PURPOSE: Convenient and effective methods for administering potential antiepileptic drugs (AEDs) chronically should facilitate many experiments in animal models of chronic epilepsy with spontaneous recurrent seizures. This proof-of-principle study aimed to optimize a once-per-day, drug-in-food protocol by testing the effect of carbamazepine (CBZ) on the frequency of convulsive seizures in rats with kainate-induced epilepsy.
METHODS: Adult male rats were given repeated low-dose kainate injections until convulsive status epilepticus persisted for >3 h. After the rats developed spontaneous recurrent seizures, food pellets with CBZ (30, 100, or 300 mg/kg/day) were provided once per day in three 2-week trials (n = 7-9 rats) involving 5 days of CBZ or control treatment, separated by two recovery days within a trial. The total amount of food provided and consumed per day corresponded to a normal caloric diet (60 g/kg/day). KEY
FINDINGS: When provided once per day, all animals ate the CBZ-containing food irregularly but continuously throughout the 24-h day. With this daily feeding protocol, CBZ significantly reduced the frequency of spontaneous convulsive seizures in a dose-dependent manner. It is important to note that the effect of CBZ was consistent across the 5 days and throughout each day of the trials. With food administered at 9:00 a.m., and blood assayed at 5:00 p.m., higher food levels of CBZ resulted in higher plasma concentrations of CBZ. SIGNIFICANCE: This AED-in-food protocol is simple, efficient, inexpensive, reliable, and noninvasive; it allows easier long-term drug administration and is less stressful and more humane than other methods of AED administration. Wiley Periodicals, Inc.
© 2011 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22092257     DOI: 10.1111/j.1528-1167.2011.03314.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  5 in total

Review 1.  Issues related to development of antiepileptogenic therapies.

Authors:  Asla Pitkänen; Astrid Nehlig; Amy R Brooks-Kayal; F Edward Dudek; Daniel Friedman; Aristea S Galanopoulou; Frances E Jensen; Rafal M Kaminski; Jaideep Kapur; Henrik Klitgaard; Wolfgang Löscher; Istvan Mody; Dieter Schmidt
Journal:  Epilepsia       Date:  2013-08       Impact factor: 5.864

Review 2.  Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs.

Authors:  Wolfgang Löscher
Journal:  Neurochem Res       Date:  2017-03-13       Impact factor: 3.996

Review 3.  Animal models of temporal lobe epilepsy following systemic chemoconvulsant administration.

Authors:  Maxime Lévesque; Massimo Avoli; Christophe Bernard
Journal:  J Neurosci Methods       Date:  2015-03-10       Impact factor: 2.390

4.  Staged anticonvulsant screening for chronic epilepsy.

Authors:  Yevgeny Berdichevsky; Yero Saponjian; Kyung-Il Park; Bonnie Roach; Wendy Pouliot; Kimberly Lu; Waldemar Swiercz; F Edward Dudek; Kevin J Staley
Journal:  Ann Clin Transl Neurol       Date:  2016-10-18       Impact factor: 4.511

5.  Effects of Antiepileptic Drugs on Spontaneous Recurrent Seizures in a Novel Model of Extended Hippocampal Kindling in Mice.

Authors:  Hongmei Song; Uilki Tufa; Jonathan Chow; Nila Sivanenthiran; Chloe Cheng; Stellar Lim; Chiping Wu; Jiachun Feng; James H Eubanks; Liang Zhang
Journal:  Front Pharmacol       Date:  2018-05-18       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.